HOYA Corporation (HOCPF)
USD 138.44
(0.0%)
USD 138.44
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 199.48 Billion JPY | 197.84% |
| 2023 | 230.99 Billion JPY | 13.34% |
| 2022 | 203.81 Billion JPY | 19.59% |
| 2021 | 170.42 Billion JPY | -7.87% |
| 2020 | 184.97 Billion JPY | 4.79% |
| 2019 | 176.51 Billion JPY | 1.14% |
| 2018 | 174.53 Billion JPY | 7.75% |
| 2017 | 161.97 Billion JPY | -5.07% |
| 2016 | 170.63 Billion JPY | 1.11% |
| 2015 | 168.75 Billion JPY | 10.18% |
| 2014 | 153.15 Billion JPY | -5.59% |
| 2013 | 162.22 Billion JPY | 7.62% |
| 2012 | 150.74 Billion JPY | -4.57% |
| 2011 | 157.96 Billion JPY | 35.55% |
| 2010 | 116.53 Billion JPY | -10.91% |
| 2009 | 130.81 Billion JPY | 5.82% |
| 2008 | 123.61 Billion JPY | 44.63% |
| 2007 | 85.47 Billion JPY | 20.21% |
| 2006 | 71.09 Billion JPY | 9.0% |
| 2005 | 65.22 Billion JPY | 7.65% |
| 2004 | 60.59 Billion JPY | 0.93% |
| 2003 | 60.03 Billion JPY | 5.12% |
| 2002 | 57.1 Billion JPY | 1.34% |
| 2001 | 56.35 Billion JPY | 10.32% |
| 2000 | 51.08 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 62.38 Billion JPY | 6.13% |
| 2024 FY | 309.65 Billion JPY | 34.06% |
| 2024 Q4 | 105.17 Billion JPY | 5.32% |
| 2024 Q3 | 99.85 Billion JPY | 4.95% |
| 2024 Q2 | 95.14 Billion JPY | 52.51% |
| 2023 FY | 230.99 Billion JPY | 13.34% |
| 2023 Q1 | 56.69 Billion JPY | 8.42% |
| 2023 Q2 | 57.88 Billion JPY | 2.11% |
| 2023 Q4 | 58.77 Billion JPY | 1.97% |
| 2023 Q3 | 57.64 Billion JPY | -0.42% |
| 2022 Q1 | 49.58 Billion JPY | 6.85% |
| 2022 FY | 203.81 Billion JPY | 19.59% |
| 2022 Q4 | 52.28 Billion JPY | 1.06% |
| 2022 Q3 | 51.73 Billion JPY | 3.06% |
| 2022 Q2 | 50.2 Billion JPY | 1.25% |
| 2021 Q1 | 34.1 Billion JPY | -25.88% |
| 2021 Q4 | 46.4 Billion JPY | 2.59% |
| 2021 Q2 | 44.67 Billion JPY | 31.01% |
| 2021 Q3 | 45.23 Billion JPY | 1.24% |
| 2021 FY | 170.42 Billion JPY | -7.87% |
| 2020 Q2 | 45.97 Billion JPY | -1.26% |
| 2020 Q3 | 46.42 Billion JPY | 0.96% |
| 2020 FY | 184.97 Billion JPY | 4.79% |
| 2020 Q1 | 46.56 Billion JPY | 3.74% |
| 2020 Q4 | 46.01 Billion JPY | -0.88% |
| 2019 Q3 | 44 Billion JPY | 0.67% |
| 2019 Q4 | 44.88 Billion JPY | 2.01% |
| 2019 Q2 | 43.71 Billion JPY | -0.45% |
| 2019 Q1 | 43.91 Billion JPY | 0.87% |
| 2019 FY | 176.51 Billion JPY | 1.14% |
| 2018 Q1 | 42.22 Billion JPY | -1.14% |
| 2018 FY | 174.53 Billion JPY | 7.75% |
| 2018 Q4 | 43.53 Billion JPY | -3.63% |
| 2018 Q3 | 45.17 Billion JPY | 3.61% |
| 2018 Q2 | 43.6 Billion JPY | 3.26% |
| 2017 Q1 | 40.4 Billion JPY | -2.61% |
| 2017 Q4 | 42.71 Billion JPY | 6.68% |
| 2017 Q3 | 40.03 Billion JPY | 3.15% |
| 2017 Q2 | 38.81 Billion JPY | -3.94% |
| 2017 FY | 161.97 Billion JPY | -5.07% |
| 2016 FY | 170.63 Billion JPY | 1.11% |
| 2016 Q2 | 43.75 Billion JPY | 1.19% |
| 2016 Q1 | 43.23 Billion JPY | 65.17% |
| 2016 Q4 | 41.49 Billion JPY | -1.56% |
| 2016 Q3 | 42.15 Billion JPY | -3.65% |
| 2015 FY | 168.75 Billion JPY | 10.18% |
| 2015 Q4 | 26.17 Billion JPY | -46.07% |
| 2015 Q3 | 48.53 Billion JPY | 15.78% |
| 2015 Q2 | 41.92 Billion JPY | 2.1% |
| 2015 Q1 | 41.06 Billion JPY | 62.18% |
| 2014 Q1 | 43.21 Billion JPY | -3.5% |
| 2014 FY | 153.15 Billion JPY | -5.59% |
| 2014 Q2 | 41.16 Billion JPY | -4.73% |
| 2014 Q3 | 43.45 Billion JPY | 5.57% |
| 2014 Q4 | 25.31 Billion JPY | -41.75% |
| 2013 Q4 | 44.77 Billion JPY | 14.64% |
| 2013 Q3 | 39.06 Billion JPY | 2.87% |
| 2013 Q1 | 39.29 Billion JPY | 3.32% |
| 2013 FY | 162.22 Billion JPY | 7.62% |
| 2013 Q2 | 37.97 Billion JPY | -3.38% |
| 2012 Q1 | 38.78 Billion JPY | -2.33% |
| 2012 Q2 | 37.97 Billion JPY | -2.11% |
| 2012 Q3 | 35.94 Billion JPY | -5.34% |
| 2012 FY | 150.74 Billion JPY | -4.57% |
| 2012 Q4 | 38.03 Billion JPY | 5.82% |
| 2011 Q4 | 39.71 Billion JPY | 36.55% |
| 2011 Q1 | 30.71 Billion JPY | 2.92% |
| 2011 Q2 | 29.33 Billion JPY | -4.46% |
| 2011 Q3 | 29.08 Billion JPY | -0.87% |
| 2011 FY | 157.96 Billion JPY | 35.55% |
| 2010 Q3 | 29.28 Billion JPY | 1.43% |
| 2010 Q4 | 29.83 Billion JPY | 1.88% |
| 2010 Q2 | 28.87 Billion JPY | 1.18% |
| 2010 Q1 | 28.53 Billion JPY | -4.71% |
| 2010 FY | 116.53 Billion JPY | -10.91% |
| 2009 Q1 | 35.39 Billion JPY | -11.29% |
| 2009 Q3 | 31.35 Billion JPY | -8.1% |
| 2009 Q4 | 29.94 Billion JPY | -4.48% |
| 2009 FY | 130.81 Billion JPY | 5.82% |
| 2009 Q2 | 34.11 Billion JPY | -3.62% |
| 2008 FY | 123.61 Billion JPY | 44.63% |
| 2008 Q4 | 39.9 Billion JPY | 2.46% |
| 2008 Q3 | 38.94 Billion JPY | 79.07% |
| 2008 Q2 | 21.74 Billion JPY | -5.52% |
| 2008 Q1 | 23.01 Billion JPY | 0.0% |
| 2007 FY | 85.47 Billion JPY | 20.21% |
| 2006 FY | 71.09 Billion JPY | 9.0% |
| 2005 FY | 65.22 Billion JPY | 7.65% |
| 2004 FY | 60.59 Billion JPY | 0.93% |
| 2003 FY | 60.03 Billion JPY | 5.12% |
| 2002 FY | 57.1 Billion JPY | 1.34% |
| 2001 FY | 56.35 Billion JPY | 10.32% |
| 2000 FY | 51.08 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -6966655.805% |
| Ansell Limited | 495.5 Million USD | -40158.527% |
| Ansell Limited | 495.5 Million USD | -40158.527% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -240808.07% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -11525556.996% |
| Psykey, Inc. | 1.21 Million USD | -16438654.656% |
| ConvaTec Group Plc | 910.31 Million USD | -21813.385% |
| ConvaTec Group Plc | 872.5 Million USD | -22763.152% |
| Encision Inc. | 3.77 Million USD | -5281723.369% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -140666702.998% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -181460088.664% |
| Innovative MedTech Inc. | 6.09 Million USD | -3270615.975% |
| LifePoint, Inc. | 7.42 Million USD | -2686921.729% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -3141827.863% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -23331011.111% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -27471551.238% |
| Reflect Scientific, Inc. | 1.06 Million USD | -18753419.558% |
| SmileDirectClub, Inc. | 517 Million USD | -38484.109% |
| Sector 10, Inc. | 39.84 Thousand USD | -500654954.713% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | -2902.86% |
| SheerVision, Inc. | 2.33 Million USD | -8555312.833% |
| United Health Products, Inc. | 2.42 Million USD | -8220703.375% |
| Vasamed, Inc. | 4.67 Million USD | -4268778.049% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -7786639.345% |
| Yubo International Biotech Limited | 1.25 Million USD | -15858471.003% |